Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MenAfriVac: A 40 cent shot to clean up meningitis in Africa

This article was originally published in Scrip

Executive Summary

The new MenAfriVac vaccine has dramatically reduced meningitis A rates in Africa. Data presented at the World Vaccines Congress (11-12 April 2012) by the Meningitis Vaccine Project revealed both a dramatic reduction in the overall number of meningitis cases, and an even more dramatic reduction in the incidence of disease caused by meningococcal A strain.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC016994

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel